180 related articles for article (PubMed ID: 34278446)
1. Apelin‑13 alleviates diabetic nephropathy by enhancing nitric oxide production and suppressing kidney tissue fibrosis.
Gao Z; Zhong X; Tan YX; Liu D
Int J Mol Med; 2021 Sep; 48(3):. PubMed ID: 34278446
[TBL] [Abstract][Full Text] [Related]
2. Astragaloside IV protects against diabetic nephropathy via activating eNOS in streptozotocin diabetes-induced rats.
Fan Y; Fan H; Zhu B; Zhou Y; Liu Q; Li P
BMC Complement Altern Med; 2019 Dec; 19(1):355. PubMed ID: 31805910
[TBL] [Abstract][Full Text] [Related]
3. The role of adrenomedullin and receptors in glomerular hyperfiltration in streptozotocin-induced diabetic rats.
Hiragushi K; Wada J; Eguchi J; Matsuoka T; Yasuhara A; Hashimoto I; Yamashita T; Hida K; Nakamura Y; Shikata K; Minamino N; Kangawa K; Makino H
Kidney Int; 2004 Feb; 65(2):540-50. PubMed ID: 14717924
[TBL] [Abstract][Full Text] [Related]
4. Renoprotective effect of atorvastatin on STZ-diabetic rats through attenuating kidney-associated dysmetabolism.
Zhou S; Zhao P; Li Y; Deng T; Tian L; Li H
Eur J Pharmacol; 2014 Oct; 740():9-14. PubMed ID: 25008071
[TBL] [Abstract][Full Text] [Related]
5. Apelin‑13 ameliorates metabolic and cardiovascular disorders in a rat model of type 2 diabetes with a high‑fat diet.
Li M; Fang H; Hu J
Mol Med Rep; 2018 Dec; 18(6):5784-5790. PubMed ID: 30387843
[TBL] [Abstract][Full Text] [Related]
6. Role of renal nitric oxide synthase in diabetic kidney disease during the chronic phase of diabetes.
Khamaisi M; Keynan S; Bursztyn M; Dahan R; Reinhartz E; Ovadia H; Raz I
Nephron Physiol; 2006; 102(3-4):p72-80. PubMed ID: 16319502
[TBL] [Abstract][Full Text] [Related]
7. Liraglutide ameliorates renal injury in streptozotocin‑induced diabetic rats by activating endothelial nitric oxide synthase activity via the downregulation of the nuclear factor‑κB pathway.
Zhou SJ; Bai L; Lv L; Chen R; Li CJ; Liu XY; Yu DM; Yu P
Mol Med Rep; 2014 Nov; 10(5):2587-94. PubMed ID: 25215431
[TBL] [Abstract][Full Text] [Related]
8. Piperazine ferulate ameliorates the development of diabetic nephropathy by regulating endothelial nitric oxide synthase.
Yang YY; Shi LX; Li JH; Yao LY; Xiang DX
Mol Med Rep; 2019 Mar; 19(3):2245-2253. PubMed ID: 30664213
[TBL] [Abstract][Full Text] [Related]
9. RAAS inhibitors directly reduce diabetes-induced renal fibrosis via growth factor inhibition.
Koszegi S; Molnar A; Lenart L; Hodrea J; Balogh DB; Lakat T; Szkibinszkij E; Hosszu A; Sparding N; Genovese F; Wagner L; Vannay A; Szabo AJ; Fekete A
J Physiol; 2019 Jan; 597(1):193-209. PubMed ID: 30324679
[TBL] [Abstract][Full Text] [Related]
10. Dencichine ameliorates renal injury by improving oxidative stress, apoptosis and fibrosis in diabetic rats.
Huang C; Cheng L; Feng X; Li X; Wang L
Life Sci; 2020 Oct; 258():118146. PubMed ID: 32721462
[TBL] [Abstract][Full Text] [Related]
11. Low nitric oxide bioavailability upregulates renal heparin binding EGF-like growth factor expression.
Miyazawa T; Zeng F; Wang S; Fan X; Cheng H; Yang H; Bian A; Fogo AB; Harris RC
Kidney Int; 2013 Dec; 84(6):1176-88. PubMed ID: 23760291
[TBL] [Abstract][Full Text] [Related]
12. Protective effect of C-peptide on experimentally induced diabetic nephropathy and the possible link between C-peptide and nitric oxide.
Elbassuoni EA; Aziz NM; El-Tahawy NF
Appl Physiol Nutr Metab; 2018 Jun; 43(6):617-624. PubMed ID: 29351386
[TBL] [Abstract][Full Text] [Related]
13. Protective effects of allicin on streptozotocin-induced diabetic nephropathy in rats.
Huang H; Jiang Y; Mao G; Yuan F; Zheng H; Ruan Y; Wu T
J Sci Food Agric; 2017 Mar; 97(4):1359-1366. PubMed ID: 27363537
[TBL] [Abstract][Full Text] [Related]
14. NAD(P)H oxidase and uncoupled nitric oxide synthase are major sources of glomerular superoxide in rats with experimental diabetic nephropathy.
Satoh M; Fujimoto S; Haruna Y; Arakawa S; Horike H; Komai N; Sasaki T; Tsujioka K; Makino H; Kashihara N
Am J Physiol Renal Physiol; 2005 Jun; 288(6):F1144-52. PubMed ID: 15687247
[TBL] [Abstract][Full Text] [Related]
15. Angiotensin II type 1 receptor blocker ameliorates uncoupled endothelial nitric oxide synthase in rats with experimental diabetic nephropathy.
Satoh M; Fujimoto S; Arakawa S; Yada T; Namikoshi T; Haruna Y; Horike H; Sasaki T; Kashihara N
Nephrol Dial Transplant; 2008 Dec; 23(12):3806-13. PubMed ID: 18596126
[TBL] [Abstract][Full Text] [Related]
16. Oxidative stress and nitric oxide synthase in rat diabetic nephropathy: effects of ACEI and ARB.
Onozato ML; Tojo A; Goto A; Fujita T; Wilcox CS
Kidney Int; 2002 Jan; 61(1):186-94. PubMed ID: 11786100
[TBL] [Abstract][Full Text] [Related]
17. Mycophenolate mofetil ameliorates diabetic nephropathy through epithelial mesenchymal transition in rats.
Xiao X; Wang J; Chang X; Zhen J; Zhou G; Hu Z
Mol Med Rep; 2015 Sep; 12(3):4043-4050. PubMed ID: 26080907
[TBL] [Abstract][Full Text] [Related]
18. Extracellular superoxide dismutase ameliorates streptozotocin-induced rat diabetic nephropathy via inhibiting the ROS/ERK1/2 signaling.
Kuo CW; Shen CJ; Tung YT; Chen HL; Chen YH; Chang WH; Cheng KC; Yang SH; Chen CM
Life Sci; 2015 Aug; 135():77-86. PubMed ID: 26006040
[TBL] [Abstract][Full Text] [Related]
19. BAY 11-7082 ameliorates diabetic nephropathy by attenuating hyperglycemia-mediated oxidative stress and renal inflammation via NF-κB pathway.
Kolati SR; Kasala ER; Bodduluru LN; Mahareddy JR; Uppulapu SK; Gogoi R; Barua CC; Lahkar M
Environ Toxicol Pharmacol; 2015 Mar; 39(2):690-9. PubMed ID: 25704036
[TBL] [Abstract][Full Text] [Related]
20. Protective effect of Icariin on the early stage of experimental diabetic nephropathy induced by streptozotocin via modulating transforming growth factor β1 and type IV collagen expression in rats.
Qi MY; Kai-Chen ; Liu HR; Su YH; Yu SQ
J Ethnopharmacol; 2011 Dec; 138(3):731-6. PubMed ID: 22027446
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
